Market Cap 15.86M
Revenue (ttm) 120,000.00
Net Income (ttm) -14.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -12,308.33%
Debt to Equity Ratio 0.00
Volume 25,800
Avg Vol 436,118
Day's Range N/A - N/A
Shares Out 8.52M
Stochastic %K 0%
Beta 2.41
Analysts Strong Buy
Price Target N/A

Company Profile

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dos...

Industry: Scientific & Technical Instruments
Sector: Technology
Phone: 281 898 6586
Address:
3050 Post Oak Boulevard, Suite 510-T80, Houston, United States
Hard6and8
Hard6and8 Jun. 22 at 3:34 PM
$AIMD 🍻
0 · Reply
LuckyInvested
LuckyInvested Jun. 22 at 1:30 PM
$AIMD — VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence https://finance.yahoo.com/technology/ai/articles/vasro-research-highlights-ainos-expansion-130000631.html?.tsrc=rss
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 22 at 1:00 PM
$AIMD VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
0 · Reply
VASROGmbH
VASROGmbH Jun. 22 at 9:58 AM
$AIMD Ainos is taking AI Nose from reading rooms to reading breath. The new National Taiwan University study is not commercial proof yet, but it is a real clinical step: testing whether AI-analyzed breath patterns can help separate COPD flare-ups from acute heart failure in emergency patients. That matters because both can look similar when a patient arrives short of breath, but treatment decisions are different. Our read: very constructive, but still early. The real proof will be validation data and whether this can move into recurring SmellTech revenue. The direction is worth watching. Not financial advice.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 11:38 PM
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 3:26 AM
1 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 1:59 AM
$AIMD looks ready
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 7:28 PM
$AIMD this move has a surprisingly mature feel to it.
0 · Reply
Hard6and8
Hard6and8 Jun. 17 at 2:50 PM
$AIMD I feel a big partnership in the next year coming here!🍻
0 · Reply
BogaTrades
BogaTrades Jun. 17 at 2:25 PM
$AIMD Get ready
0 · Reply
Latest News on AIMD
Ainos Transcript: RedChip Future Tech Investor Conference

Jun 10, 2026, 11:30 AM EDT - 14 days ago

Ainos Transcript: RedChip Future Tech Investor Conference


Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Jun 8, 2026, 8:00 AM EDT - 16 days ago

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders


Ainos launches research program at NTUH to deploy AI Nose

2026-06-01T15:09:04.000Z - 23 days ago

Ainos launches research program at NTUH to deploy AI Nose


Ainos Earnings release: Q1 2026

May 13, 2026, 4:00 PM EDT - 6 weeks ago

Ainos Earnings release: Q1 2026


Ainos Quarterly report: Q1 2026

May 13, 2026, 4:00 PM EDT - 6 weeks ago

Ainos Quarterly report: Q1 2026


Ainos Slides: Investor presentation

Apr 6, 2026, 7:00 AM EDT - 2 months ago

Ainos Slides: Investor presentation


Ainos reports FY25 revenue $124,157 vs. $20,729 last year

2026-03-30T13:19:48.000Z - 3 months ago

Ainos reports FY25 revenue $124,157 vs. $20,729 last year


Ainos Earnings release: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 3 months ago

Ainos Earnings release: Q4 2025


Ainos Annual report: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 3 months ago

Ainos Annual report: Q4 2025


Ainos says WSJ highlights emerging ‘Smell AI’ in article

2026-03-19T12:51:19.000Z - 3 months ago

Ainos says WSJ highlights emerging ‘Smell AI’ in article


Ainos announces interim results from VELDONA clinical trial

2026-02-17T13:42:11.000Z - 4 months ago

Ainos announces interim results from VELDONA clinical trial


Ainos Transcript: Fireside chat

Jan 26, 2026, 11:00 AM EST - 5 months ago

Ainos Transcript: Fireside chat


Ainos enters distribution agreement with Trusval Technology

2026-01-07T13:51:09.000Z - 6 months ago

Ainos enters distribution agreement with Trusval Technology


Ainos to relocate U.S. headquarter to Houston, Texas

2025-12-16T13:45:41.000Z - 6 months ago

Ainos to relocate U.S. headquarter to Houston, Texas


Ainos Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:15 PM EST - 7 months ago

Ainos Reports Third Quarter 2025 Financial Results


Ainos Earnings release: Q3 2025

Nov 13, 2025, 4:00 PM EST - 7 months ago

Ainos Earnings release: Q3 2025


Ainos Quarterly report: Q3 2025

Nov 13, 2025, 4:00 PM EST - 7 months ago

Ainos Quarterly report: Q3 2025


Ainos, NEXCOM partner to expand AI nose ecosystem

2025-10-14T12:46:09.000Z - 9 months ago

Ainos, NEXCOM partner to expand AI nose ecosystem


Ainos Proxy statement: Proxy Filing

Oct 1, 2025, 8:00 AM EDT - 9 months ago

Ainos Proxy statement: Proxy Filing


Ainos to Showcase AI Nose at SEMICON Taiwan 2025

Sep 8, 2025, 9:30 AM EDT - 10 months ago

Ainos to Showcase AI Nose at SEMICON Taiwan 2025


Ainos Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:15 PM EDT - 11 months ago

Ainos Reports Second Quarter 2025 Financial Results


Ainos Earnings release: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

Ainos Earnings release: Q2 2025


Ainos Quarterly report: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

Ainos Quarterly report: Q2 2025


Hard6and8
Hard6and8 Jun. 22 at 3:34 PM
$AIMD 🍻
0 · Reply
LuckyInvested
LuckyInvested Jun. 22 at 1:30 PM
$AIMD — VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence https://finance.yahoo.com/technology/ai/articles/vasro-research-highlights-ainos-expansion-130000631.html?.tsrc=rss
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 22 at 1:00 PM
$AIMD VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
0 · Reply
VASROGmbH
VASROGmbH Jun. 22 at 9:58 AM
$AIMD Ainos is taking AI Nose from reading rooms to reading breath. The new National Taiwan University study is not commercial proof yet, but it is a real clinical step: testing whether AI-analyzed breath patterns can help separate COPD flare-ups from acute heart failure in emergency patients. That matters because both can look similar when a patient arrives short of breath, but treatment decisions are different. Our read: very constructive, but still early. The real proof will be validation data and whether this can move into recurring SmellTech revenue. The direction is worth watching. Not financial advice.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 11:38 PM
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 3:26 AM
1 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 18 at 1:59 AM
$AIMD looks ready
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 7:28 PM
$AIMD this move has a surprisingly mature feel to it.
0 · Reply
Hard6and8
Hard6and8 Jun. 17 at 2:50 PM
$AIMD I feel a big partnership in the next year coming here!🍻
0 · Reply
BogaTrades
BogaTrades Jun. 17 at 2:25 PM
$AIMD Get ready
0 · Reply
WaltersWhite
WaltersWhite Jun. 17 at 1:30 PM
$AIMD — Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program https://finance.yahoo.com/healthcare/articles/ainos-expands-smell-ai-platform-120000206.html?.tsrc=rss
0 · Reply
STACKD0E
STACKD0E Jun. 17 at 12:34 PM
0 · Reply
Hard6and8
Hard6and8 Jun. 16 at 11:41 PM
$AIMD let’s go! Huge opportunity ahead at AIMD! 🍻
0 · Reply
Hard6and8
Hard6and8 Jun. 15 at 12:10 PM
$AIMD let’s get some press release momentum this week!🍻
0 · Reply
Hard6and8
Hard6and8 Jun. 11 at 11:15 PM
$AIMD it’s awfully quiet around here but I have a lot of faith of big things ahead for AIMD!🍻
0 · Reply
Hard6and8
Hard6and8 Jun. 4 at 1:01 PM
$AIMD $3+ by end of July!🍻
0 · Reply
VASROGmbH
VASROGmbH Jun. 4 at 7:51 AM
$AIMD AI Nose just moved into a live emergency room at National Taiwan University Hospital. That matters beyond the numbers. This is not just another pilot. It puts Ainos’ Smell AI inside one of the hardest real-world environments: crowd density, patient flow, infection-risk signals, no images, no audio, no personal data. The key question now is simple: can this move from research program to recurring SmellTech deployment? That is the real value marker we are watching. Based on VASRO’s latest Ainos update report. https://vasro.de/en/portfolios/ainos-inc/
0 · Reply
Hard6and8
Hard6and8 Jun. 3 at 12:01 PM
$AIMD let’s have a day!🍻
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 3 at 12:00 AM
$YMAT $ASTC $MOBX $UZX $AIMD good ones part two
0 · Reply
Hard6and8
Hard6and8 Jun. 2 at 6:20 PM
$AIMD 1-2 years from now if this goes as planned I am very curious where this ends up. Opportunity is enormous!🍻
0 · Reply
ZacksSCR
ZacksSCR Jun. 2 at 4:16 PM
$AIMD Ainos, Inc. is using machine olfaction to detect contamination in chip manufacturing before it affects yield. https://youtu.be/SJTc4prVTag
1 · Reply
Hard6and8
Hard6and8 Jun. 1 at 4:38 PM
$AIMD let’s find that next move up on some news release this week! Need to find a way to bounce back over next few weeks to high 2’s!🍻
0 · Reply